Food and milk allergies and immune system development courses, infographics, and videos.
This continuing education course discusses the microbiome in early life immune development and protection from allergic disorders, the potential impact of COVID-19 on its development, and the dietary factors that support the microbiome's interactions with the immune system.
In this course, identify research on how 2′-FL HMO helps narrow differences between formula and breast milk; review clinical studies supporting HMOs in immune support; and discuss why 2′-FL HMO may be relevant for the dietary management of infants with food allergy.
An infographic reference guide to rapidly evaluate and help manage CMA that can be given to a child’s caregiver.
These online modules bring together scientific experts from around the world to share their knowledge and experience in the nutritional management of food allergies. There are five episodes in this series.
A video featuring professor Christine Loscher as she discusses normal immune development in infants; reviews the dysregulation in the immune system that results in allergic responses; describes how we can manipulate the immune system to overcome this dysregulation; and explains the differences between breastfed and bottle-fed infants.
In this video, Carina Venter reviews the different presentations of cow’s milk allergy (CMA); discusses diagnostic tests for CMA; reviews the importance of the clinical history for diagnosis of CMA; and describes healthcare professional tools for managing CMA.
This course describes normal immune development and differences between breastfed and bottle-fed infants; it discusses the dysregulation in the immune system that results in allergic responses; defines the role of human milk oligosaccharides (HMOs) in breast milk; and evaluates the current state of evidence for the role of HMOs in diseases and disorders. Originally presented as a live webinar on June 3, 2020.
This course reviews clinical studies supporting the immune benefits of 2'-fucosyllactose human milk oligosaccharide (2'-FL HMO); discusses preclinical evidence of 2'-FL HMO effects on food allergy and potential mechanisms of action; and describes the possible role of 2'-FL HMO in enhancing oral tolerance. Originally presented as a live webinar on June 3, 2020.
This course defines cow’s milk allergy (CMA); discusses its clinical features; reviews dietary management; and review case study presentations.
The content on this website is intended solely for healthcare professionals in the United States.
Please be aware that the website you have requested to view is intended for Healthcare Professionals and may not be owned or maintained by Abbott. A new window will open in your browser once you select “yes”. You can return to this site by clicking the back arrow.
Do you wish to continue and exit this website?
